Cargando…
Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models
Ginsenoside Rg3 (Rg3) has two epimers, 20(S)-ginsenoside Rg3 (SRg3) and 20(R)-ginsenoside Rg3 (RRg3), and while Rg3 itself has been reported to have anti-cancer properties, few studies have been reported on the anti-cancer effects of the different epimers. The aim was to investigate the stereoselect...
Autores principales: | Nakhjavani, Maryam, Palethorpe, Helen M., Tomita, Yoko, Smith, Eric, Price, Timothy J., Yool, Andrea J., Pei, Jinxin V., Townsend, Amanda R., Hardingham, Jennifer E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789838/ https://www.ncbi.nlm.nih.gov/pubmed/31374984 http://dx.doi.org/10.3390/ph12030117 |
Ejemplares similares
-
Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models
por: Nakhjavani, Maryam, et al.
Publicado: (2021) -
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019) -
Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments
por: Nakhjavani, Maryam, et al.
Publicado: (2021) -
Anti-Angiogenic Properties of Ginsenoside Rg3
por: Nakhjavani, Maryam, et al.
Publicado: (2020) -
Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019)